Page 2051 - Hematology_ Basic Principles and Practice ( PDFDrive )

1820.e2 Part XI Transfusion Medicine

epidemic in Brazil. [Available at: https://jid.oxfordjournals.org/content/ 62. Dumont Larry, Kleinman S, Murphy JR, et al: Screening of single-donor
early/2015/07/09/infdis.jiv326.full (Accessed 28.01.16).]. apheresis platelets for bacterial contamination: the PASSPORT study
46. Stramer SL, Hollinger FB, Katz LM, et al: Emerging infectious disease results. Transfusion 50:589, 2010.
agents and their potential threat to transfusion safety. Transfusion 49:1S, 63. Jacobs Michael, Smith D, Heaton WA, et al: Detection of bacterial
2009. contamination in prestorage culture negative apheresis platelets on day
47. Stramer SL, Dodd RY, for the AABB Transfusion-Transmitted Diseases of issue with the PGD test. Transfusion 51:2573, 2011.
Emerging Infectious Diseases Subgroup: Transfusion-transmitted emerg- 64. Zou S, Notari EP, Fang CT, et al: Current value of serologic test for
ing infectious diseases: 30 years of challenges and progress. Transfusion syphilis as a surrogate marker for blood borne viral infections among
53:2375–2383, 2013. blood donors in the United States. Transfusion 49:655, 2009.
48. Lombardi VC, Ruscetti FW, Das Gupta J, et al: Detection of an infec- 65. Townsend RL, Moritz ED, Fialkow LB, et al: Probable transfusion-
tious retrovirus, XMRV, in blood cells of patients with chronic fatigue transmission of Anaplasma phagocytophilum by leukoreduced platelets.
syndrome. Science 326:585, 2009. Transfusion 54:2828–2832, 2014.
49. Paprotka T, Delviks-Frankenberry KA, Cingöz O, et al: Recombinant 66. Mali S, Tan DR, Arquin PM: Malaria surveillance—United States, 2009,
origin of the retrovirus XMRV. Science 333:97, 2011. (vol 60). 2011, MMWR Surveill Summ, p 1.
50. Dodd RY, Hackett JR, Jr, Linnen JM, et al: Xenotropic murine leukemia 67. Spencer Bryan, Kleinman S, Custer B, et al: Deconstructing the Risk
virus-related virus does not pose a risk to blood recipient safety. Transfu- for Malaria in United States Donors Deferred for Travel to Mexico.
sion 52:298–306, 2012. Transfusion 51:2398, 2011.
51. Chiu C, Bres V, Yu G, et al: Genomic assays for identification of chi- 68. Leiby David: Transfusion-Transmitted Babesia spp.: Bull’s-Eye on Babesia
kungunya virus in blood donors, Puerto Rico, 2014. Emerg Infect Dis microti. Clin Microbiol Rev 24:14, 2011.
21:1409–1413, 2015. 69. Herwaldt BL, Linden JV, Bosserman E, et al: Transfusion-associated
52. Brouard C, Bernillon P, Quatresous I, et al: Estimated risk of chikungu- babesiosis in the United States: a description of cases. Ann Intern Med
nya viremic blood donation during an epidemic on Reunion Island in 155:509, 2011.
the Indian Ocean, 2005-2007. Transfusion 48:1333–1341, 2008. 70. Moritz ED, Winton CS, Johnson ST, et al: Investigational screening
53. Musso D, Nhan T, Robin E, et al: Potential for Zika virus transmis- for Babesia microti in a large repository of blood donor samples from
sion through blood transfusion demonstrated during an outbreak in nonendemic and endemic areas of the United States. Transfusion
French Polynesia, November 2013 to February 2014. Euro Surveill 54:2226–2236, 2014.
19(14):pii=20761, 2014. 71. Cardo Lisa J: Leishmania: risk to the blood supply. Transfusion 46:1641,
54. Fauci AS, Morens DM: Zika virus in the Americas—Yet another arbo- 2006.
virus threat. N Engl J Med 374:601–604, 2016. 72. Benjamin RJ, Stramer SL, Leiby DA, et al: Trypanosoma cruzi infec-
55. Hennessey M, Fischer M, Staples JE: Zika virus spreads to new areas— tion in North America and Spain: evidence in support of transfusion
Region of the Americas, May 2015-January 2016. MMWR 65(3):55–58, transmission. Transfusion 52:1913–1921, 2012.
2016. 73. Cantey PT, Stramer SL, Townsend RL, et al: The United States Trypano-
56. Schuler-Faccini L, Ribeiro EM, Feitosa IML, et al: Possible associa- soma cruzi Infection Study: evidence for vector-borne transmission of the
tion between Zika virus infection and microencephaly—Brazil, 2015. parasite that causes Chagas disease among United States blood donors.
MMWR 65(3):1–4, 2016. Transfusion 52:1922–1930, 2012.
57. Musso D, Roche C, Robin E, et al: Potential sexual transmission of Zika 74. Food and Drug Administration: Guidance for industry: Use of
virus. Emerg Infect Dis 21:359–361, 2015. serological tests to reduce the risk of transmission of Trypanosoma cruzi
58. Likos AM, Kelvin DJ, Cameron CM, National Heart, Lung, Blood infection in whole blood and blood components intended for transfusion.
Institute Retrovirus Epidemiology Donor Study-II (REDS-II), et al: 12/2010. Available at http://www.fda.gov/BiologicsBloodVaccines/
Influenza viremia and the potential for blood-borne transmission. GuidanceComplianceRegulatoryInformation/Guidances/Blood/
Transfusion 47:1080, 2007. ucm235855.htm. Accessed 08.23.11.
59. Stramer SL, Collins C, Nugent T, et al: Sensitive detection assays for 75. Steele WR, Hewitt EH, Kaldun AM, et al: Donors deferred for
influenza RNA do not reveal viremia in US blood donors. J Infect Dis self-reported Chagas disease history: does it reduce risk? Transfusion
205(6):886, 2012. 54:2092–2097, 2014.
60. Food and Drug Administration: Fatalities reported to FDA following 76. Dorsey K, Zou S, Schonberger LB, et al: Lack of evidence of transfusion
blood collection and transfusion. Annual summary for fiscal year 2010. transmission of Creutzfeldt-Jakob disease in a US surveillance study.
pp. 1–12. Available at http://www.fda.gov/BiologicsBloodVaccines/ Transfusion 49:977–984, 2009.
SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ 77. Food and Drug Administration: Revised preventive measures to reduce
ucm254802.htm. Accessed 08.29.11. the possible risk of transmission of Creutzfeldt-Jakob disease and variant
61. Eder AF, Meena-Leist CE, Hapip CA, et al: Clostridium perfringens in Creutzfeldt-Jakob disease by blood and blood products. Revised, January 2016.
apheresis platelets: an unusual contaminant underscores the importance Available at http://www.fda.gov/downloads/BiologicsBloodVaccines/
of clinical vigilance for septic transfusion reactions. Transfusion 857–862, GuidanceComplianceRegulatoryInformation/Guidances/Blood/
2014. UCM307137.pdf. Accessed 09.02.16.